$KACL
Kairous Acquisition Corp. Ltd Stock $kacl

$kacl Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222032901 Filed on November 18, 2022

Income Statement

Concept	2022 Q3	2021 Q3
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$196.3K	$5.720K
YoY Change	3331.99%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$196.3K	$12.03K
YoY Change	1531.82%
Operating Profit	-$196.3K	-$5.724K
YoY Change	3329.56%
Interest Expense	$355.6K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$355.6K
YoY Change
Pretax Income	$159.3K	-$12.03K
YoY Change	-1424.02%
Income Tax
% Of Pretax Income
Net Earnings	$159.3K	-$12.03K
YoY Change	-1424.06%
Net Earnings / Revenue
Basic Earnings Per Share	$0.02	$0.00
Diluted Earnings Per Share	$15.70K	-$1.233K
COMMON SHARES
Basic Shares Outstanding	10.15M shares	1.875M shares
Diluted Shares Outstanding	10.15M shares

Balance Sheet

Concept	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$341.4K	$56.96K
YoY Change	499.4%
Cash & Equivalents	$341.4K	$56.96K
Short-Term Investments
Other Short-Term Assets	$95.87K	$2.980K
YoY Change	3117.11%
Inventory
Prepaid Expenses	$95.87K
Receivables
Other Receivables
Total Short-Term Assets	$437.3K	$59.95K
YoY Change	629.41%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$79.25M
YoY Change
Other Assets	$13.98K	$251.8K
YoY Change	-94.45%
Total Long-Term Assets	$79.26M	$251.8K
YoY Change	31382.73%
TOTAL ASSETS
Total Short-Term Assets	$437.3K	$59.95K
Total Long-Term Assets	$79.26M	$251.8K
Total Assets	$79.70M	$311.7K
YoY Change	25468.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.37K
YoY Change
Accrued Expenses	$15.00K	$15.00K
YoY Change	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$70.00K	$70.00K
YoY Change	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$150.4K	$298.8K
YoY Change	-49.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.730M
YoY Change
Total Long-Term Liabilities	$2.730M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$150.4K	$298.8K
Total Long-Term Liabilities	$2.730M	$0.00
Total Liabilities	$2.880M	$298.8K
YoY Change	864.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.429M
YoY Change
Common Stock	$235.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.429M	$12.97K
YoY Change
Total Liabilities & Shareholders Equity	$79.70M	$311.7K
YoY Change	25468.25%

Cashflow Statement

Concept	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	$159.3K	-$12.03K
YoY Change	-1424.06%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$141.5K	-$5.720K
YoY Change	2374.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		62.69K
YoY Change
NET CHANGE
Cash From Operating Activities	-$141.5K	-5.720K
Cash From Investing Activities
Cash From Financing Activities		62.69K
Net Change In Cash	-$141.5K	56.97K
YoY Change	-348.46%
FREE CASH FLOW
Cash From Operating Activities	-$141.5K	-$5.720K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001865468
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2021Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense		usd
CY2021Q3	KACL	Interest Income InterestIncome		usd
CY2021Q3	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2021Q3	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2021Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2021Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities		usd
CY2022Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022Q3	KACL	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty		usd
CY2022Q3	KACL	Prepaid Operating Costs Paid By Related Party PrepaidOperatingCostsPaidByRelatedParty		usd
CY2021Q3	KACL	Current Period Remeasurement Adjustment Of Ordinary Shares To Redemption Value CurrentPeriodRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue		usd
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	001-41155
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	Kairous Acquisition Corp. Limited
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	Unit 9-3, Oval Tower @ Damansara
CY2022Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 685, Jalan Damansara
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60000
CY2022Q3	dei	Entity Address Address Line3 EntityAddressAddressLine3	Taman Tun Dr. Ismail
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
CY2022Q3	dei	Entity Address Country EntityAddressCountry	MY
CY2022Q3	dei	City Area Code CityAreaCode	+603
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	7733 9340
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q3	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q3	dei	Entity Shell Company EntityShellCompany	true
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10146143	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	341417	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	482965	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	95867	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	110116	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	437284	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	593081	usd
CY2022Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	79250093	usd
CY2022Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	78894512	usd
CY2022Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	13983	usd
CY2022Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	25363	usd
CY2022Q3	us-gaap	Assets Assets	79701360	usd
CY2022Q2	us-gaap	Assets Assets	79512956	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	65370	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	36250	usd
CY2022Q3	KACL	Accrued Offering Costs Current AccruedOfferingCostsCurrent	15000	usd
CY2022Q2	KACL	Accrued Offering Costs Current AccruedOfferingCostsCurrent	15000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	70000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	70000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	150370	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	121250	usd
CY2022Q3	KACL	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent	2730000	usd
CY2022Q2	KACL	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent	2730000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2880370	usd
CY2022Q2	us-gaap	Liabilities Liabilities	2851250	usd
CY2022Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	7800000	shares
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	79250093	usd
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	78894512	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2346143	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2346143	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2346143	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2346143	shares
CY2022Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares	7800000	shares
CY2022Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares	7800000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	235	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	235	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2429338	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2233041	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2429103	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2232806	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79701360	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79512956	usd
CY2022Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	15000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	181308	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5724	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	196308	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	5724	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-196308	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5724	usd
CY2022Q3	KACL	Interest Income InterestIncome	11	usd
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet	355581	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	355592	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	159284	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5724	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10146143	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1875000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2232806	usd
CY2022Q3	KACL	Temporary Equity Remeasurement To Redemption Value Adjustment TemporaryEquityRemeasurementToRedemptionValueAdjustment	-355581	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	159284	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2429103	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18695	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5724	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12971	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	159284	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5724	usd
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet	355581	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-14249	usd
CY2022Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-11380	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	29120	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-141548	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5724	usd
CY2021Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	70000	usd
CY2021Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7312	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62688	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-141548	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	56964	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	482965	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	341417	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56964	usd
CY2021Q3	KACL	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty	2012	usd
CY2021Q3	KACL	Prepaid Operating Costs Paid By Related Party PrepaidOperatingCostsPaidByRelatedParty	2983	usd
CY2022Q3	KACL	Current Period Remeasurement Adjustment Of Ordinary Shares To Redemption Value CurrentPeriodRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue	355581	usd
CY2021Q4	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	4843252	usd
CY2021Q4	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1559900	usd
CY2021Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	2730000	usd
CY2021Q4	KACL	Other Offering Costs OtherOfferingCosts	553352	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2730000	usd
CY2022Q3	KACL	Condition For Future Business Combination Use Of Proceeds Percentage ConditionForFutureBusinessCombinationUseOfProceedsPercentage	0.80	pure
CY2022Q3	KACL	Condition For Future Business Combination Threshold Percentage Ownership ConditionForFutureBusinessCombinationThresholdPercentageOwnership	0.50	pure
CY2022Q3	KACL	Threshold Percentage Of Public Shares Subject To Redemption Without Companys Prior Written Consent ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanysPriorWrittenConsent	0.15	pure
CY2022Q3	KACL	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
CY2022Q3	KACL	Redemption Period Upon Closure RedemptionPeriodUponClosure	P12M
CY2022Q3	KACL	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
CY2022Q3	KACL	Maximum Net Interest To Pay Dissolution Expenses MaximumNetInterestToPayDissolutionExpenses	100000	usd
CY2022Q3	KACL	Working Capital WorkingCapital	286914	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	341417	usd
CY2022Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zIoThAwS8HKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zmZXJSEmX4xl">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Cash Cash	341417	usd
CY2022Q2	us-gaap	Cash Cash	482965	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	79300000	usd
CY2022Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	78900000	usd
CY2022Q3	KACL	Offering Costs Associated With Initial Public Offering OfferingCostsAssociatedWithInitialPublicOffering	<p id="xdx_84D_ecustom--OfferingCostsAssociatedWithInitialPublicOffering_znZvhvrpPewb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zhI0LfMfaSx3">Offering Costs associated with the Initial Public Offering</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with the requirements of the Financial Accounting Standards Board (“FASB”) ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, <i>“Expenses of Offering.”</i> Offering costs of $<span id="xdx_906_eus-gaap--OperatingCostsAndExpenses_c20220701__20220930__us-gaap--IncomeStatementLocationAxis__custom--OtherCostMember_zBZlrleJmaS3" title="Transaction costs">894,582</span> consisted principally of costs incurred in connection with preparation for the Initial Public Offering. These offering costs, together with the underwriter fees of $<span id="xdx_90D_ecustom--UnderwriterFee_c20220701__20220930_zAHrwkpoMvB7" title="Underwriter fees">4,289,900</span> (or $<span id="xdx_90C_eus-gaap--PaymentsForUnderwritingExpense_c20220701__20220930_z5tsz4j7E3X3" title="Underwriting fees">1,559,900</span> paid in cash upon the closing of the Initial Public Offering and a deferred fee of $<span id="xdx_90A_eus-gaap--OtherUnderwritingExpense_c20220701__20220930__us-gaap--SubsidiarySaleOfStockAxis__custom--DeferredUnderwritingCommissionsMember_zMa2CmE0oaWk" title="Deferred underwriter fees">2,730,000</span>), were charged to stockholders’ equity upon completion of the Initial Public Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	KACL	Underwriter Fee UnderwriterFee	4289900	usd
CY2022Q3	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1559900	usd
CY2022Q3	KACL	Temporary Equity Subject To Possible Redemption TemporaryEquitySubjectToPossibleRedemption	7800000	shares
CY2022Q2	KACL	Temporary Equity Subject To Possible Redemption TemporaryEquitySubjectToPossibleRedemption	7800000	shares
CY2022Q3	KACL	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	79250093	usd
CY2022Q2	KACL	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	78894512	usd
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zXIGMeXZONi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zPayi68xLLNg">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zjWbPZSHDLU3" title="Cash FDIC insured amount">250,000</span>. The Company has not experienced losses on this account. The Company has not experienced any losses on the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/> </p>
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	341230	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	KACL	Shares Subject To Mandatory Redemption Settlement Terms Shares SharesSubjectToMandatoryRedemptionSettlementTermsShares	7800000	shares
CY2022Q2	KACL	Shares Subject To Mandatory Redemption Settlement Terms Shares SharesSubjectToMandatoryRedemptionSettlementTermsShares	0	shares
CY2022Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Description SharesSubjectToMandatoryRedemptionSettlementTermsDescription	if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders

Files In Submission

Name	View Source	Status
0001493152-22-032901-index-headers.html	Edgar Link	pending
0001493152-22-032901-index.html	Edgar Link	pending
0001493152-22-032901.txt	Edgar Link	pending
0001493152-22-032901-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kacl-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kacl-20220930_lab.xml	Edgar Link	unprocessable
kacl-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
kacl-20220930_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
kacl-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KACL
Kairous Acquisition Corp. Ltd Stock $kacl

2022 Q3 Form 10-Q Financial Statement

#000149315222032901 Filed on November 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KACL Kairous Acquisition Corp. Ltd Stock $kacl

2022 Q3 Form 10-Q Financial Statement

#000149315222032901 Filed on November 18, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KACL
Kairous Acquisition Corp. Ltd Stock $kacl